BioNexus Gene Lab Corp Common stock (BGLC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.00B
EV to revenue ratio (TTM)
0.03
EV to ebitda
629.53
Financial Performance
Revenue (TTM)
$0.00B
Gross profit (TTM)
$0.00B
EBITDA
-$0.00B
Profitability
Operating margin (TTM)
-398.70%
Profit margin
-82.40%
Return on assets (TTM)
-19.00%
Return on equity (TTM)
-33.70%
Per Share Metrics
Revenue per share (TTM)
$1.44
EPS
-$1.26
Diluted EPS (TTM)
-$1.26
Book value
$3.22
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
0.77
Price to book ratio (TTM)
0.31
Growth
Quarterly earnings growth (YoY)
-96.60%
Quarterly revenue growth (YoY)
-95.00%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
1.97